Table 2: Rates of completion of diabetes management tests and of on-target values.
| Practice no. | Management indicator; no. (%) of patients | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hemoglobin A1c | Fasting blood glucose | Blood pressure | Low-density lipoprotein cholesterol | Urine albumin:creatinine ratio | ||||||
| Completed* | On target† | Completed* | On target† | Completed* | On target† | Completed* | On target† | Completed* | On target† | |
| All (n = 6673) | 4592 (68.8) | 2676 (58.3) | 3245 (48.6) | 1524 (47.0) | 5645 (84.6) | 2109 (37.4) | 3890 (58.3) | 2240 (57.6) | 2075 (31.1) | 939 (45.2) |
| 1 (n = 735) | 592 (80.5) |
340 (57.4) |
353 (48.0) |
164 (46.5) |
710 (96.6) |
225 (31.7) |
478 (65.0) |
251 (52.5) |
329 (44.8) |
156 (47.4) |
| 2 (n = 295) | 235 (79.7) |
129 (54.9) |
112 (38.0) |
54 (48.2) |
284 (96.3) |
94 (33.1) |
194 (65.8) |
109 (56.2) |
136 (46.1) |
69 (50.7) |
| 3 (n = 315) | 274 (87.0) |
154 (56.2) |
252 (80.0) |
112 (44.4) |
284 (90.2) |
124 (43.7) |
235 (74.6) |
131 (55.7) |
156 (49.5) |
82 (52.6) |
| 4 (n = 208) | 99 (47.6) |
69 (69.7) |
153 (73.6) |
109 (71.2) |
200 (96.2) |
70 (35.0) |
158 (76.0) |
51 (32.3) |
47 (22.6) |
27 (57.4) |
| 5 (n = 809) | 96 (11.9) |
47 (49.0) |
84 (10.4) |
35 (41.7) |
671 (82.9) |
215 (32.0) |
77 (9.5) |
36 (46.8) |
29 (3.6) |
19 (65.5) |
| 6 (n = 392) | 349 (89.0) |
193 (55.3) |
280 (71.4) |
115 (41.1) |
366 (93.4) |
232 (63.4) |
309 (78.8) |
208 (67.3) |
179 (45.7) |
84 (46.9) |
| 7 (n = 542) | 432 (79.7) |
267 (61.8) |
241 (44.5) |
109 (45.2) |
409 (75.5) |
192 (46.9) |
334 (61.6) |
223 (66.8) |
164 (30.3) |
56 (34.1) |
| 8 (n = 832) | 706 (84.9) |
471 (66.7) |
645 (77.5) |
332 (51.5) |
736 (88.5) |
318 (43.2) |
609 (73.2) |
384 (63.1) |
356 (42.8) |
159 (44.7) |
| 9 (n = 647) | 375 (58.0) |
197 (52.5) |
406 (62.8) |
208 (51.2) |
475 (73.4) |
128 (26.9) |
373 (57.7) |
168 (45.0) |
188 (29.1) |
52 (27.7) |
| 10 (n = 191) | 157 (82.2) |
100 (63.7) |
144 (75.4) |
60 (41.7) |
170 (89.0) |
66 (38.8) |
132 (69.1) |
76 (57.6) |
64 (33.5) |
29 (45.3) |
| 11 (n = 304) | 213 (70.1) |
95 (44.6) |
198 (65.1) |
71 (35.9) |
201 (66.1) |
92 (45.8) |
204 (67.1) |
116 (56.9) |
105 (34.5) |
51 (48.6) |
| 12 (n = 170) | 131 (77.1) |
77 (58.8) |
31 (18.2) |
16 (51.6) |
144 (84.7) |
76 (52.8) |
101 (59.4) |
78 (77.2) |
14 (8.2) |
8 (57.1) |
| 13 (n = 448) | 326 (72.8) |
150 (46.0) |
109 (24.3) |
34 (31.2) |
377 (84.2) |
69 (18.3) |
179 (40.0) |
73 (40.8) |
71 (15.8) |
31 (43.7) |
| 14 (n = 504) | 373 (74.0) |
231 (61.9) |
126 (25.0) |
52 (41.3) |
484 (96.0) |
148 (30.6) |
291 (57.7) |
183 (62.9) |
172 (34.1) |
84 (48.8) |
| 15 (n = 281) | 234 (83.3) |
156 (66.7) |
111 (39.5) |
53 (47.7) |
134 (47.7) |
60 (44.8) |
216 (76.9) |
153 (70.8) |
65 (23.1) |
32 (49.2) |
*p < 0.001 for difference in proportion of patients who had test completed across practices (χ2 test).
†p < 0.001 for difference in proportion of patients who had indicator value on target across practices (χ2 test).